Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?

Key Takeaways McKesson Corporation (MCK) is scheduled to report first-quarter fiscal 2026 results on Aug. 6, after market close. The company delivered an earnings surprise of 3.16% in the last reported quarter. Its earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 3.93%. McKesson's revenue growth has been driven largely by the rapid adoption of GLP-1 weight loss drugs and sustained demand for branded pharmaceuticals, both of which have fueled s ...